Refine by
Biomarker Development Articles & Analysis
52 articles found
Diverse Applications: Where Luminex Shines Human Luminex Multiplex Assay Panels are instrumental across numerous research and development fields: Biomarker Discovery & Validation: Identifying and validating novel protein biomarkers for disease diagnosis, prognosis, and therapeutic response in areas like oncology, immunology, neurology, and ...
Autoimmune and Inflammatory Diseases: Cytokines are central to the development and progression of autoimmune and inflammatory diseases. Customized assays can help identify biomarkers and therapeutic targets. Drug Development: Evaluating the impact of new drugs on cytokine profiles is essential for assessing their efficacy and safety. ...
Additionally, multiplex cytokine analysis is a valuable tool in vaccine development and drug discovery, providing real-time feedback on immune modulation. ...
Understanding how proteins bind to other molecules—be it DNA, small molecules, or other proteins—is essential for advancing drug discovery, biomarker research, and therapeutic development. When applied to protein analysis, SPR protein studies focus on identifying and characterizing the dynamic interactions between a "ligand" (the molecule ...
Understanding and analyzing these biomolecules has become increasingly important in areas such as disease research, biomarker discovery, and drug development. NAD and NADH are not merely passive participants in metabolism—they are regulatory molecules that influence key metabolic pathways, including glycolysis, oxidative phosphorylation, and biosynthetic ...
By analyzing these interactions, scientists can identify new biomarkers for disease, develop targeted therapies, or discover novel glycan-binding proteins with potential applications in drug design. 2. ...
By analyzing lipid profiles and identifying specific lipid biomarkers, researchers can develop strategies for disease prevention and diagnosis. ...
De Novo protein sequencing can help researchers identify new potential drug targets, promoting the development of new drugs.3. Biomarker DiscoveryFinding biomarkers associated with specific diseases or biological processes is crucial for early diagnosis and treatment. De Novo protein sequencing can help identify potential ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. ...
Discovery and Validation of Disease BiomarkersIt's used to identify protein expression changes associated with specific diseases (such as cancer, cardiovascular disease, neurodegenerative diseases, etc.) to discover potential biomarkers.2. Research on Drug Action MechanismAnalyzing samples before and after drug treatment to reveal the molecular targets and mechanisms of drugs, ...
These analyses help understand the biological meaning of changes in protein expression, such as disease mechanisms, discovery of biomarkers, or studies of drug action.TMT technology, with its high sensitivity and ability to handle large-scale comparative analysis, is increasingly being recognized in proteomics research, especially in the fields of disease mechanism research, drug ...
Bioinformatics AnalysisBioinformatics tools and software can be used to predict potential glycosylation sites by identifying possible glycosylation sites by analyzing the features of protein or nucleic acid sequences.Glycosylation plays a key role in the development of many diseases. For example, in cancer, abnormal glycosylation patterns may lead to changes in protein function, ...
For specific acetylation site localization, mass spectrometry is usually the preferred method.Changes in the acetylation level of a specific protein are related to the development of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. ...
Quantitative analysis of phosphoproteomics helps us to better understand cellular signaling mechanisms, discover disease biomarkers, drive drug development, and achieve precision treatment. Several methods have been established to quantify changes in protein phosphorylation, some of which include:1. ...
With the continuous development of mass spectrometry technology, proteins, as the direct executors of many biological functions, are receiving more and more attention, especially the proteins in exosomes and their biological functions. ...
Cancer is a daunting diagnosis; however, the rapid advancements in oncology are continuously perfecting patient outcomes and quality of life. Among the groundbreaking developments, cancer vaccines are a promising frontier1. These vaccines are transforming how we approach cancer treatment, leveraging the body's immune system to fight malignancies more effectively. ...
Changes in the quantity of protein biomarkers can directly reflect the development of the disease. Therefore, by detecting the absolute quantity of biomarkers at different stages of the disease, the development of the disease can be judged intuitively. ...
With professional knowledge of PC (particularly intra-tumor heterogeneity, TME crosstalk, and micro-environmental instability) and powerful cross-platform collaboration capability, Alfa Cytology has launched a series of PC vaccine development services to meet pre-clinical research needs. The PC vaccine development services at Alfa Cytology are more targeted ...
Modified proteomics provides us with key clues to unravel these disease mechanisms, helping us better understand the nature of diseases and offering new avenues for disease prevention and treatment. 3. Basis for Drug Development The interaction between drugs and proteins is at the heart of drug development. ...
With the continuous deepening of biomedical research, proteomics is playing an increasingly important role in the research of disease mechanisms, the discovery of biomarkers, and the development of new drugs. Particularly in the screening of differential proteins, proteomics technology provides a powerful tool, helping researchers reveal the dynamic changes of ...